§ 23-79-1701. Title

This subchapter shall be known and may be cited as the “Emerging Therapy Act of 2017”.

§ 23-79-1702. Definitions

As used in this subchapter: (1) “Board” means the State and Public School Life and Health Insurance Board; (2) “Choosing Wisely Initiative” means the initiative established by the American Board of Internal Medicine Foundation that seeks to advance a national dialogue on avoiding wasteful or unnecessary medical tests, treatments, and procedures; (3) “Emerging therapies” means […]

§ 23-79-1703. State and Public School Life and Health Insurance Board — Requirements

(a) By the end of plan year 2017, the State and Public School Life and Health Insurance Board shall explore the evidence supporting opportunities for benefit modification informed by: (1) The Choosing Wisely Initiative; (2) Emerging therapies; and (3) Therapeutic alternatives to invasive surgical procedures, such as regenerative injection therapy. (b) By July 2018, the […]

§ 23-79-1704. Legislative findings

The General Assembly finds that: (1) The State and Public School Life and Health Insurance Board has a fiduciary obligation to explore cost-effective treatments for its members; (2) There are emerging technologies that could serve as cost-effective alternatives to surgical procedures; and (3) Clinical organizations are increasingly providing public guidance on quality treatment practices.